Siyao Huang
Overview
Explore the profile of Siyao Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He M, Cao L, Liu L, Jin X, Zheng B, Liu X, et al.
J Med Virol
. 2024 Jan;
96(2):e29411.
PMID: 38285434
Cap RNA methylations play important roles in the replication, evasion of host RNA sensor recognition, and pathogenesis. Coronaviruses possess both guanine N7- and 2'-O-ribose methyltransferases (N7-MTase and 2'-O-MTase) encoded by...
2.
Hou Y, Cao C, Chiba H, Chang Z, Huang S, Zhu L, et al.
Mol Phylogenet Evol
. 2023 Jun;
186:107865.
PMID: 37352994
The range of the butterfly genus Pseudocoladenia includes several biodiversity hotspots, such as the Himalayas, mountains of southwestern China, and Sundaland. However, the taxonomic status of some of its species/subspecies...
3.
Liu L, Du J, Yang S, Zheng B, Shen J, Huang J, et al.
Redox Biol
. 2023 May;
63:102752.
PMID: 37245288
Viral infection-induced cell death has long been considered as a double-edged sword in the inhibition or exacerbation of viral infections. Patients with severe Coronavirus Disease 2019 (COVID-19) are characterized by...
4.
Yang Y, Cao L, Yan M, Zhou J, Yang S, Xu T, et al.
Antiviral Res
. 2023 Mar;
213:105586.
PMID: 36997073
S-217622 (Ensitrelvir) is a reversible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3-chymotrypsin-like protease (3CL) inhibitor which obtained emergency regulatory approval in Japan for the treatment of SARS-CoV-2 infection on...
5.
Zeng W, Xing F, Ji Y, Yang S, Xu T, Huang S, et al.
Front Cell Infect Microbiol
. 2022 Jun;
12:911313.
PMID: 35755832
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initially described to target the respiratory system and now has been reported to infect a variety of cell types, including cardiomyocytes,...
6.
Cao L, Li Y, Yang S, Li G, Zhou Q, Sun J, et al.
Sci Transl Med
. 2022 May;
14(661):eabm7621.
PMID: 35579533
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus driving the ongoing coronavirus disease 2019 (COVID-19) pandemic, continues to rapidly evolve. Because of the limited efficacy of vaccination in prevention...
7.
Yang S, Cao L, Xu W, Xu T, Zheng B, Ji Y, et al.
J Med Virol
. 2022 Mar;
94(8):3605-3612.
PMID: 35355296
A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been identified as the causative agent of the current coronavirus disease 2019 pandemic. Development of animal models that parallel...
8.
Zhang Y, Huang S, Wang M
Biodivers Data J
. 2022 Feb;
10:e78167.
PMID: 35210917
Background: The tribe Arctiini is a species-rich tribe of the subfamily Arctiinae of the family Erebidae. The genus Watson, 1980 is distributed in the Oriental and Palearctic Regions and the...
9.
Cao L, Xu T, Liu X, Ji Y, Huang S, Peng H, et al.
Front Cell Infect Microbiol
. 2022 Feb;
12:823306.
PMID: 35155280
SARS-CoV-2 is evolving with mutations throughout the genome all the time and a number of major variants emerged, including several variants of concern (VOC), such as Delta and Omicron variants....
10.
Liu X, Guo L, Xu T, Lu X, Ma M, Sheng W, et al.
Virus Evol
. 2022 Jan;
7(2):veab104.
PMID: 35039785
SARS-CoV-2, which causes the current pandemic of respiratory illness, is evolving continuously and generating new variants. Nevertheless, most of the sequence analyses thus far focused on nucleotide substitutions despite the...